BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4710038)

  • 61. [Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)].
    Bauer HW; Richter H; Schottler S; Ax W
    Chir Forum Exp Klin Forsch; 1978; (1978):215-9. PubMed ID: 752589
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunologic study of carcinoma of the digestive tract. Effects of the tumor stage. I. Cellular immunity in the preoperative period.
    Sanz ML; Subirá ML; Oehling A; Hernández JL; Zornoza G
    Allergol Immunopathol (Madr); 1982; 10(1):33-42. PubMed ID: 7080994
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nature and significance of the antigens associated with human gastrointestinal tumours.
    Burtin P
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():115-8. PubMed ID: 4598346
    [No Abstract]   [Full Text] [Related]  

  • 64. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 65. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune stimulation-inhibition of experimental cancer metastasis.
    Fidler IJ
    Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
    [No Abstract]   [Full Text] [Related]  

  • 67. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Induction of antibodies to viscotoxins A1, A2, A3, and B in tumour patients during therapy with an aqueous mistletoe extract.
    Klein R; Classen K; Fischer S; Errenst M; Scheffler A; Stein GM; Scheer R; von Laue HB
    Eur J Med Res; 2002 Aug; 7(8):359-67. PubMed ID: 12204844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study.
    Stephenson HE; Delmez JA; Renden DI; Kimpton RS; Todd PC; Charron TL; Lindberg DA
    Surg Gynecol Obstet; 1971 Oct; 133(4):649-55. PubMed ID: 5106992
    [No Abstract]   [Full Text] [Related]  

  • 70. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
    Hellström I; Hellström KE
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
    [No Abstract]   [Full Text] [Related]  

  • 71. [Evidence for tumor immunity in human malignant melanoma].
    Nagel GA
    Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
    [No Abstract]   [Full Text] [Related]  

  • 72. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
    Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Lim M; Weber CE; Baccala AA; Goemann MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF; Nelson WG
    Cancer Res; 1999 Oct; 59(20):5160-8. PubMed ID: 10537292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 74. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 75. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 76. Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test.
    Takasugi M; Terasaki PI
    J Natl Cancer Inst; 1972 Nov; 49(5):1229-37. PubMed ID: 4675381
    [No Abstract]   [Full Text] [Related]  

  • 77. Evidence for tumor-specific antigens in filtered tissue culture media from human cancer cells.
    Hickok DF; Miller L
    In Vitro; 1974; 10(3-4):157-66. PubMed ID: 4452557
    [No Abstract]   [Full Text] [Related]  

  • 78. [The effect of lymphocytes on the human breast cancer cell in vitro].
    Liu HC; Prigenzi LS; Pinotti JA
    AMB Rev Assoc Med Bras; 1978 Feb; 24(2):44-6. PubMed ID: 306636
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunocompetence testing in patients with one of the four common operable cancers--a review.
    Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
    Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
    [No Abstract]   [Full Text] [Related]  

  • 80. [Colorectal neoplasms: preoperative determination of GICA].
    Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
    Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.